Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

INmune Bio, Inc.   NASDAQ (INMB)

18.25    $-0.41   -2.20%
At close   Monday, Oct 18 04:00 PM

INmune Bio, Inc. Chart

INMB Stock Price Today

INmune Bio, Inc. (INMB) stock plummeted over -2.20% intraday to trade at $18.25 a share on NASDAQ. The stock opened with a gain of 0.48% at $18.75 and touched an intraday high of $19.13, rising 2.52% against the last close of $18.66. The stock went to a low of $18.02 during the session.

Stock Snapshot

18.66
Prev. Close
18.75
Open
326.86M
Market Cap
14.97M
Number of Shares
18.02
day Low
19.13
Day High
18.25
-
P/E ratio
8.70%
Free Float in %
-1.37
EPS (TTM)
2.89
Book Value per Share
2.21
Cash Flow per Share
158541
Volume

INmune Bio, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-10-19$$18.25$$158,541
2021-10-18$$18.66$$88,878
2021-10-04$19.23$18.54$19.85$18.43295,247
2021-10-01$19.23$19.19$19.53$18.4062,266
2021-09-30$19.38$19.42$20.23$19.03262,134
2021-09-10$21.68$21.40$22.27$20.82374,174
2021-09-03$23.43$26.43$26.74$22.4478,920,000
2021-09-02$25.16$24.02$26.46$23.79128,850,000
2021-09-01$23.47$23.87$24.57$23.07116,230,000
2021-08-31$22.59$23.72$23.79$21.4545,320,000
2021-08-30$20.51$22.60$23.76$20.3378,640,000

Contact Details

1200 Prospect Street
Suite 525
La Jolla, CA 92037
United States
http://www.inmunebio.com
858 964 3720

About Company

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03 that treats patients with advanced cancers with elevated biomarkers of inflammation in their blood; XPro1595 for the treatment of Alzheimer's disease; LivNate to treat patients with non-alcoholic steatohepatitis; and Quellor for cytokine release syndrome and complications of COVID-19. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in La Jolla, California.

Frequently Asked Questions

What is the current INmune Bio, Inc. (INMB) stock price?

INmune Bio, Inc. (NASDAQ: INMB) stock price is $18.25 as of the last check on Monday, Oct 18. During the trading session, INMB stock reached the peak price of $19.13 while $18.02 was the lowest point it dropped to.

INMB's industry and sector of operation?

The NASDAQ listed INMB is part of Biotechnology industry that operates in the broader Healthcare sector. INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis.

Who are the executives of INMB?

Dr. Raymond Joseph Tesi
Co-Founder, Pres, CEO, Chief Medical Officer & Chairman

Mr. David J. Moss M.B.A.
CFO, Treasurer & Sec.

Dr. Mark William Lowdell BSc, MSc, Ph.D., FRCPath,
Chief Scientific Officer & Chief Manufacturing Officer

Mr. Joshua S. Schoonover Esq.
Assoc. Gen. Counsel


What is the INMB stock price today?

INMB stock traded closed the last session at $18.25, which is $-0.41 or -2.20% lower than its previous close of $18.66. INMB's current trading price is -39.91% lower than its 52-week high of $30.37 where as its distance from 52-week low of $7.28 is 150.69%.

How many employees does INMB have?

Number of INMB employees currently stands at 5. INMB operates from 1200 Prospect Street Suite 525 La Jolla, CA 92037 United States.

Link for INMB official website?


How do I contact INMB?

INMB could be contacted at 1200 Prospect Street Suite 525 La Jolla, CA 92037 United States, or at phone # 858 964 3720 and can also be accessed through its website: http://www.inmunebio.com

How many shares of INMB are traded daily?

INMB stock volume for the day was 158541 shares while in the previous session number of INMB shares traded was 158541. The average number of INMB shares traded daily for last 3 months was 474400.

How much did INMB change today?

The percentage change in INMB stock occurred in the recent session was -2.20% while the dollar amount for the price change in INMB stock was $-0.41.

What price range INMB stock been trading in?

In the recent session, the day high for INMB stock was $19.13 while the low for INMB stock touched on the day was $18.02.

What is the market cap of INMB currently?

The market value of INMB currently stands at $326.86M with its latest stock price at $18.25 and 14.97M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam